GORHAM MEDICAL LIMITEDActive

Company number 06844330Private limited companyIncorporated 2009

Key figures

£187,048+2.3%
Net assets 2024/25
+19.9%
Average annual growth 2019/20–2024/25
050 k100 k150 k200 k2019/202020/212021/222022/232023/242024/25

GORHAM MEDICAL LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Profit for the year77,89911,4807,81610,1924,291
Cash at bank and in hand57,535981,828220,69811,4797,903
Total assets528,9491,168,673674,598522,605793,881
Total liabilities376,9021,004,840502,720—611,907
Net assets / total equity153,269164,749172,565182,757187,048
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: GORHAM MEDICAL LIMITED

Company

GORHAM MEDICAL LIMITED is a private limited company registered with Companies House under company number 06844330. It was incorporated on 11 Mar 2009. Its status is active. The registered office is in Slough (SL3). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files small company accounts. Profit for the year was £4,291. Net assets were £187,048, up 2.3% on the previous year. Cash at bank and in hand was £7,903. Total assets were £793,881 and total liabilities £611,907. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 4 of 5 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 25 Mar 2027.